MetaADEDB 2.0 @ LMMD
Glycine
(DHMQDGOQFOQNFH-UHFFFAOYSA-N)
Structure
SMILES
NCC(=O)O
Type(s)
Approved; Nutraceutical; Vet_approved
ATC code(s)
B05CX03
Molecular Formula:
C2H5NO2
Molecular Weight:
75.067
Log P:
-0.2700
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
63.32
CAS Number(s):
56-40-6; 18875-39-3; 25718-94-9
Synonym(s)
1.
Glycine
2.
Aminoacetic Acid
3.
Glycine Carbonate (1:1), Monosodium Salt
4.
Glycine Carbonate (2:1), Monolithium Salt
5.
Glycine Carbonate (2:1), Monopotassium Salt
6.
Glycine Carbonate (2:1), Monosodium Salt
7.
Glycine Hydrochloride
8.
Glycine Hydrochloride (2:1)
9.
Glycine Phosphate
10.
Glycine Phosphate (1:1)
11.
Glycine Sulfate (3:1)
12.
Glycine, Calcium Salt
13.
Glycine, Calcium Salt (2:1)
14.
Glycine, Cobalt Salt
15.
Glycine, Copper Salt
16.
Glycine, Monoammonium Salt
17.
Glycine, Monopotasssium Salt
18.
Glycine, Monosodium Salt
19.
Glycine, Sodium Hydrogen Carbonate
20.
Acid, Aminoacetic
21.
Calcium Salt Glycine
22.
Cobalt Salt Glycine
23.
Copper Salt Glycine
24.
Hydrochloride, Glycine
25.
Monoammonium Salt Glycine
26.
Monopotasssium Salt Glycine
27.
Monosodium Salt Glycine
28.
Phosphate, Glycine
29.
Salt Glycine, Monoammonium
30.
Salt Glycine, Monosodium
External Link(s)
MeSHD005998
PubChem Compound750
5257127
BindingDB18133
ChEBI57305
15428
CHEMBLCHEMBL773
DrugBankDB00145
DrugCentral1319
IUPHAR/BPS Guide to PHARMACOLOGY727
4084
4635
KEGGcpd:C00037
dr:D00011
Therapeutic Target DatabaseD00KUW
D0M8AB
D09LLO
ZINC4658552
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Electrolyte imbalanceFAERS: 2SIDER
US FAERS
2Accidental exposure to productFAERS: 1US FAERS
3Blood osmolarity decreasedFAERS: 1US FAERS
4Blood sodium abnormalFAERS: 1US FAERS
5BradycardiaFAERS: 1US FAERS
6HypotensionFAERS: 1SIDER
US FAERS
7HypoventilationFAERS: 1US FAERS
8AcidosisSIDER
9Angina PectorisSIDER
10Back PainSIDER
11ChillsSIDER
12DehydrationSIDER
13Digitalis toxicitySIDER
14DiuresisSIDER
15DizzinessSIDER
16Fluid overloadSIDER
17HypersensitivitySIDER
18LightheadednessSIDER
19NauseaSIDER
20PainSIDER
21PolyuriaSIDER
22Pulmonary congestionSIDER
23Respiratory tract congestionSIDER
24RhinitisSIDER
25TachycardiaSIDER
26ThirstSIDER
27ThrombophlebitisSIDER
28Toxicity to various agentsSIDER
29Urinary RetentionSIDER
30UrticariaSIDER
31VertigoSIDER
32Visual ImpairmentSIDER
33Visual disturbanceSIDER
34VomitingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.